A detailed history of Tower Research Capital LLC (Trc) transactions in Eyenovia, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,954 shares of EYEN stock, worth $895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,954
Previous 21,424 53.54%
Holding current value
$895
Previous $12,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.46 - $1.44 $5,276 - $16,516
-11,470 Reduced 53.54%
9,954 $5,000
Q2 2024

Aug 13, 2024

BUY
$0.52 - $1.06 $2,186 - $4,457
4,205 Added 24.42%
21,424 $12,000
Q1 2024

May 15, 2024

BUY
$0.99 - $2.37 $11,301 - $27,055
11,416 Added 196.73%
17,219 $17,000
Q4 2023

Feb 13, 2024

SELL
$1.08 - $2.08 $475 - $915
-440 Reduced 7.05%
5,803 $12,000
Q3 2023

Nov 14, 2023

SELL
$1.57 - $2.54 $590 - $955
-376 Reduced 5.68%
6,243 $10,000
Q2 2023

Aug 14, 2023

BUY
$2.21 - $5.75 $3,255 - $8,469
1,473 Added 28.62%
6,619 $15,000
Q1 2023

May 09, 2023

SELL
$1.72 - $3.53 $2,977 - $6,110
-1,731 Reduced 25.17%
5,146 $18,000
Q4 2022

Feb 10, 2023

SELL
$1.54 - $2.74 $11,163 - $19,862
-7,249 Reduced 51.32%
6,877 $11,000
Q3 2022

Nov 10, 2022

BUY
$1.55 - $2.48 $4,329 - $6,926
2,793 Added 24.64%
14,126 $27,000
Q2 2022

Aug 15, 2022

BUY
$1.71 - $3.26 $15,820 - $30,161
9,252 Added 444.59%
11,333 $22,000
Q1 2022

May 12, 2022

BUY
$2.66 - $3.99 $5,248 - $7,872
1,973 Added 1826.85%
2,081 $6,000
Q4 2021

Feb 14, 2022

BUY
$3.5 - $6.58 $378 - $710
108 New
108 $0
Q3 2021

Nov 15, 2021

SELL
$3.97 - $5.64 $7,666 - $10,890
-1,931 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$4.36 - $5.75 $1,892 - $2,495
-434 Reduced 18.35%
1,931 $9,000
Q1 2021

May 17, 2021

BUY
$5.11 - $7.41 $12,085 - $17,524
2,365 New
2,365 $12,000
Q3 2020

Nov 16, 2020

SELL
$2.61 - $5.1 $3,168 - $6,191
-1,214 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$2.6 - $3.81 $3,156 - $4,625
1,214 New
1,214 $4,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $3.08M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.